Origins of Cancer Immunotherapy, ft. Dr. Steven Rosenberg
The ImmunoVerse™
00:00
Pioneering cytokine therapy with interleukin-2
Steven Rosenberg outlines developing IL-2 therapies, producing recombinant IL-2, optimizing dosing, and achieving the first systemic immunotherapy responses.
Transcript
Play full episode
